blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3724205

EP3724205 - CYCLIC DINUCLEOTIDES AS STING AGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.04.2023
Database last updated on 22.08.2024
FormerThe patent has been granted
Status updated on  20.05.2022
FormerGrant of patent is intended
Status updated on  06.02.2022
FormerExamination is in progress
Status updated on  23.04.2021
FormerRequest for examination was made
Status updated on  18.09.2020
FormerThe international publication has been made
Status updated on  21.06.2019
Formerunknown
Status updated on  18.01.2019
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): MC		published on 17.07.2024  [2024/29]
Applicant(s)For all designated states
Janssen Biotech, Inc.
800/850 Ridgeview Drive
Horsham, PA 19044 / US
[2020/43]
Inventor(s)01 / BEIGELMAN, Leonid
260 E. Grand Avenue
South San Francisco, California 94080 / US
02 / BIGNAN, Gilles
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
03 / CONNOLLY, Peter J.
c/o Janssen Research & Development, LLC
Geraldine Cooney-21-2024
1400 McKean Rd.
Spring House, PA 19477 / US
04 / EDWARDS, James Patrick
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
05 / EMANUEL, Stuart
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
06 / LAQUERRE, Sylvia
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
07 / RICHTER, Mark
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
08 / SCHEPENS, Wim Gert Griet
Turnhoutseweg 30
2340 Beerse / BE
09 / THATIKONDA, Santhosh Kumar
260 E. Grand Avenue
South San Francisco, California 94080 / US
10 / THURING, Johannes Wilhelmus John Fitzgerald
Turnhoutseweg 30
2340 Beerse / BE
11 / VIELLEVOYE, Marcel
Turnhoutseweg 30
2340 Beerse / BE
12 / WANG, Guangyi
260 E. Grand Avenue
South San Francisco, California 94080 / US
13 / ZHONG, Minghong
260 E. Grand Avenue South
San Francisco, California 94080 / US
 [2022/25]
Former [2020/43]01 / BEIGELMAN, Leonid
260 E. Grand Avenue South
San Francisco, California 94080 / US
02 / BIGNAN, Gilles
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
03 / CONNOLLY, Peter J.
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
04 / EDWARDS, James Patrick
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
05 / EMANUEL, Stuart
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
06 / LAQUERRE, Sylvia
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
07 / RICHTER, Mark
1400 Welsh and McKean Roads
Spring House, Pennsylvania 19477 / US
08 / SCHEPENS, Wim Gert Griet
Turnhoutseweg 30
2340 Beerse / BE
09 / THATIKONDA, Santhosh Kumar
260 E. Grand Avenue South
San Francisco, California 94080 / US
10 / THURING, Johannes Wilhelmus John Fitzgerald
Turnhoutseweg 30
2340 Beerse / BE
11 / VIELLEVOYE, Marcel
Turnhoutseweg 30
2340 Beerse / BE
12 / WANG, Guangyi
260 E. Grand Avenue South
San Francisco, California 94080 / US
13 / ZHONG, Minghong
260 E. Grand Avenue South
San Francisco, California 94080 / US
Representative(s)Murgitroyd & Company
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2022/25]Mitchell, Simon James
Murgitroyd & Company London
Euston House
24 Eversholt Street
London NW1 1AD / GB
Former [2020/43]Mitchell, Simon James
Urquhart-Dykes & Lord LLP
Euston House
24 Eversholt Street
London NW1 1AD / GB
Application number, filing date18830620.314.12.2018
[2020/43]
WO2018US65677
Priority number, dateUS201762599111P15.12.2017         Original published format: US 201762599111 P
[2020/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019118839
Date:20.06.2019
Language:EN
[2019/25]
Type: A1 Application with search report 
No.:EP3724205
Date:21.10.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 20.06.2019 takes the place of the publication of the European patent application.
[2020/43]
Type: B1 Patent specification 
No.:EP3724205
Date:22.06.2022
Language:EN
[2022/25]
Search report(s)International search report - published on:EP20.06.2019
ClassificationIPC:C07H21/02, A61K31/7084, C07H21/04, A61P31/00, A61P31/12, A61P35/00
[2020/43]
CPC:
C07H21/02 (EP); C07H21/00 (KR); C07H21/04 (EP,US);
A61K31/7084 (EP,KR,US); A61K9/0053 (US); A61P31/12 (KR);
A61P35/00 (KR,US); C07K16/082 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/43]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:CYCLISCHE DINUKLEOTIDE ALS STING-AGONISTEN[2020/43]
English:CYCLIC DINUCLEOTIDES AS STING AGONISTS[2020/43]
French:DINUCLÉOTIDES CYCLIQUES UTILISÉS EN TANT QU'AGONISTES DE STING[2020/43]
Entry into regional phase11.06.2020National basic fee paid 
11.06.2020Designation fee(s) paid 
11.06.2020Examination fee paid 
Examination procedure11.06.2020Examination requested  [2020/43]
11.06.2020Date on which the examining division has become responsible
26.01.2021Amendment by applicant (claims and/or description)
22.04.2021Despatch of a communication from the examining division (Time limit: M06)
02.11.2021Reply to a communication from the examining division
07.02.2022Communication of intention to grant the patent
11.05.2022Fee for grant paid
11.05.2022Fee for publishing/printing paid
11.05.2022Receipt of the translation of the claim(s)
Opposition(s)23.03.2023No opposition filed within time limit [2023/22]
Fees paidRenewal fee
14.12.2020Renewal fee patent year 03
10.11.2021Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.12.2018
AL22.06.2022
AT22.06.2022
CY22.06.2022
CZ22.06.2022
DK22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
MC22.06.2022
MK22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SI22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
IS22.10.2022
PT24.10.2022
LU14.12.2022
[2024/29]
Former [2024/27]HU14.12.2018
AL22.06.2022
AT22.06.2022
CY22.06.2022
CZ22.06.2022
DK22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
MK22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SI22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
IS22.10.2022
PT24.10.2022
LU14.12.2022
Former [2024/24]HU14.12.2018
AL22.06.2022
AT22.06.2022
CY22.06.2022
CZ22.06.2022
DK22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SI22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
IS22.10.2022
PT24.10.2022
LU14.12.2022
Former [2024/21]AL22.06.2022
AT22.06.2022
CY22.06.2022
CZ22.06.2022
DK22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SI22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
IS22.10.2022
PT24.10.2022
LU14.12.2022
Former [2023/38]AL22.06.2022
AT22.06.2022
CZ22.06.2022
DK22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SI22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
IS22.10.2022
PT24.10.2022
LU14.12.2022
Former [2023/37]AL22.06.2022
AT22.06.2022
CZ22.06.2022
DK22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SI22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
IS22.10.2022
PT24.10.2022
Former [2023/21]AL22.06.2022
AT22.06.2022
CZ22.06.2022
DK22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
IS22.10.2022
PT24.10.2022
Former [2023/17]AL22.06.2022
AT22.06.2022
CZ22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
IS22.10.2022
PT24.10.2022
Former [2023/12]AT22.06.2022
CZ22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
IS22.10.2022
PT24.10.2022
Former [2023/11]AT22.06.2022
CZ22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
PL22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
PT24.10.2022
Former [2023/09]AT22.06.2022
CZ22.06.2022
EE22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
RO22.06.2022
RS22.06.2022
SE22.06.2022
SK22.06.2022
SM22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
PT24.10.2022
Former [2023/07]AT22.06.2022
FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
RS22.06.2022
SE22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
Former [2022/50]FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
RS22.06.2022
SE22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
Former [2022/49]FI22.06.2022
HR22.06.2022
LT22.06.2022
LV22.06.2022
SE22.06.2022
BG22.09.2022
NO22.09.2022
GR23.09.2022
Former [2022/47]FI22.06.2022
LT22.06.2022
SE22.06.2022
NO22.09.2022
Cited inInternational search[I]WO2017161349  (IMMUNE SENSOR LLC [US], et al) [I] 1-25* the whole document in particular claim 1, pages 298 and 325; pages 298,325 *
ExaminationWO2020016782
by applicantWOO1002369
 WO0210192
 WO02068470
 WO2010027827
 WO2010077634
 WO2011066342
 WO2013019906
 US8383796
    - ZHONG B et al., "The Adaptor Protein MITA Links Virus-Sensing Receptors to IRF3 Transcription Factor Activation", Immunity, (20080000), vol. 29, doi:doi:10.1016/j.immuni.2008.09.003, pages 538 - 550, XP055021580

DOI:   http://dx.doi.org/10.1016/j.immuni.2008.09.003
    - LIU S et al., "Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation", Science, (20150000), pages 2630 - 2637
    - CHEN H et al., "Activation of STAT6 by STING Is Critical for Antiviral Innate Immunity", Cell, (20110000), vol. 14, pages 433 - 446
    - CORRALES, L. et al., "Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity", Cell Reports, (20150000), vol. 1, no. 1, pages 1 - 13
    - KONNO, H. et al., "Cyclic dinucleotides trigger ULK1 (ATGl) phosphorylation of STING to prevent sustained innate immune signaling", Cell, (20130000), vol. 155, doi:doi:10.1016/j.cell.2013.09.049, pages 688 - 698, XP028758016

DOI:   http://dx.doi.org/10.1016/j.cell.2013.09.049
    - SUN, L. et al., "Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway", Science, (20130000), vol. 339, doi:doi:10.1126/science.1232458, pages 786 - 791, XP055294100

DOI:   http://dx.doi.org/10.1126/science.1232458
    - BHAT N; FITZGERALD KA, "Recognition of Cytosolic DNA by cGAS and other STING-dependent sensors", Eur J Immunol., (20140300), vol. 44, no. 3, pages 634 - 40
    - ZHANG X et al., "Cyclic GMP-A]\;UJ Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING", Molecular Cell, (20130000), vol. 51, doi:doi:10.1016/j.molcel.2013.05.022, pages 226 - 235, XP055300246

DOI:   http://dx.doi.org/10.1016/j.molcel.2013.05.022
    - DANILCHANKA, O; MEKALANOS, JJ, "Cyclic Dinucleotides and the Innate Immune Response", Cell, (20130000), vol. 154, doi:doi:10.1016/j.cell.2013.08.014, pages 962 - 970, XP028706417

DOI:   http://dx.doi.org/10.1016/j.cell.2013.08.014
    - LIU S-Y et al., "Systematic identification of type I and type II interferon-induced antiviral factors", Proc. Natl. Acad. Sci., (20120000), vol. 109, pages 4239 - 4244
    - VAN DER JEUGHT et al., Oncotarget, (20150000), vol. 6, no. 3, pages 1359 - 1381
    - MARABELLE, A. et al., Clinical Cancer Research, (20140000), vol. 20, no. 7, pages 1747 - 1756
    - HOLFORD; SCHEINER, Clin. Pharmacokinet., (19980000), vol. 6, pages 429 - 453
    - LOEWE; MUISCHNEK, Arch. Exp. Pathol Pharmacol., (19260000), vol. 114, pages 313 - 326
    - CHOU; TALALAY, Adv. Enzyme Regul., (19840000), vol. 22, pages 27 - 55
    - J. Chem. Soc., Perkin Trans., (20020000), vol. 1, pages 485 - 495
    - CHEMICAL ABSTRACTS, Database accession no. 170871-87-1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.